CLVRR

Clever Leaves alt earns a Neutral rating with three-out-of-five conviction, reflecting a composite score in the high 30s and an uneven pillar profile. Regulatory is the strongest pillar at the midpoint of the scoring range, supported by a constructive LATAM jurisdiction posture and no enforcement hits. Market ranks second at 40, although the absence of an available quote constrains confirmation from institutional pricing feeds. Fundamentals and editorial trail near 30, limiting upside to the overall rating. The stretched financial condition prevents the stronger regulatory contribution from translating into an Overweight view.

Licensed fundamentals data show year-over-year revenue growth of roughly 5%, a positive but modest pace. Gross margin sits near 38%, providing some evidence of product-level economics, yet the operating margin below negative 100% indicates that operating costs materially exceed revenue. Net income remains negative at almost $18 million, while EBITDA is also negative at more than $13 million, reinforcing the stretched condition rather than signaling balance-sheet repair. Cash-runway scoring remains weak. Filing cadence is another constraint: primary regulatory filings provide no dated latest filing, while disclosed regulatory event counts remain at zero across both the 90-day and 180-day windows. The clean enforcement record supports the regulatory pillar, but the low cadence subscore limits its contribution. CIN newsroom coverage also shows no newsroom or brief activity, leaving editorial support subdued.

The clearest forward catalyst sits within regulatory, the highest-scoring pillar. A current primary regulatory filing that establishes a fresh reporting date and documents substantive jurisdictional progress would strengthen cadence while building on the existing LATAM posture and clean enforcement profile. That combination could lift the composite without relying on unsupported market-price momentum or sparse CIN newsroom coverage. Fundamentals still require measurable improvement in operating profitability and bottom-line performance before a higher rating gains support, but regulatory documentation offers the most direct path to improved conviction. The single most important signal to watch is a newly dated primary regulatory filing that materially improves filing cadence.